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Abstract
Objective: Peritonsillar abscess (PTA) is the most common deep space infection of the head and neck,
aﬀecting thousands of people annually with high treatment costs. The purpose of this project was to
determine how in-network emergency departments (EDs) adhere to generally accepted guidelines regarding
diagnosis and management of potential PTAs.
Methods: The authors performed a retrospective chart review to identify patients with PTA in ﬁve EDs in one
year. Information pertaining to diagnostic tests, treatment, and airway status was also collected. Descriptive
analysis was used to assess if EDs were consistent with generally accepted guidelines.
Results: Six hundred twenty-one patient records were identiﬁed and 140 were included in ﬁnal analysis. Out
of 140 patients, 71 were admitted for inpatient management and 23 were admitted for observation. Of the
46 patients diagnosed and discharged from the ED, 61% received a computerized tomography (CT) scan
and only 39% had PTA drainage performed. Four (3%) patients received a point of care ultrasound and a
CT scan and no patient received only an ultrasound. Out of all patients, 116/140 received a CT scan and
22 received drainage in the ED. The remainder of these patients either had drainage performed by an
otolaryngologist or had no drainage performed. Of the 94 patients admitted for inpatient or observation, 84
received a CT scan and six received drainage by an ED physician. Only 62% of patients were given a
penicillin derivative and 29% were given clindamycin, which has no Gram-negative coverage.
Conclusion: One-third of PTA patients were managed within the ED, far less than similar studies. Of these,
over 50% received a CT scan and less than 50% had PTA drainage. PTA drainage can improve patients’
symptoms and antibiotic eﬀectiveness. The majority of patients were prescribed a penicillin derivative with
or without another antibiotic.

Categories: Emergency Medicine, Otolaryngology
Keywords: peritonsillar abscess, pta, incision and drainage, emergency department, ct scan

Introduction
Peritonsillar abscess (PTA) is the most common deep space infection of the head and neck, aﬀecting
45,000 people per year with annual treatment costs of over $150 million [1]. Patients typically present with
unilateral pharyngeal discomfort, drooling, and fever [2]. PTAs present similarly to peritonsillar cellulitis;
however, management is dependent on diﬀerentiation. Diﬀerentiation can be done by identiﬁcation of pus on
needle aspiration, which is a rapid and inexpensive method, and concurrently treats a PTA [2,3]. Despite this
identiﬁcation method, computerized tomography (CT) scans are utilized in approximately 5-20% of cases
possibly because of the high sensitivity and speciﬁcity [4]. However, CT scans result in radiation doses that
may increase the rate of cancer to 390 per million persons [5]. Some providers prefer to utilize imaging prior
to PTA drainage for fear of carotid artery injury, although this has not been reported in the literature [5].
Patients can be safely monitored within the emergency department (ED) for a few hours after needle
aspiration to assess airway function and discharged with a follow-up appointment with their primary care
provider [2]. Previous research found that 80% of PTA patients in the United States are treated with
antibiotics without PTA drainage, in the ED, and discharged home with low readmission rates [4]. One study
comparing incision and drainage (I&D) with local lidocaine versus needle aspiration under general
anesthesia found shorter hospital stays and a lower risk of repeated procedures if the patient was treated
with an initial I&D [6]. A clear protocol with well-deﬁned admission criteria can aid physicians in assessing
and treating PTA [7].
According to the American Family Physicians guidelines and the literature, PTAs should be treated in an
outpatient setting with oral antibiotics, drainage, and steroids [2]. Adequate antibiotic coverage should
include Gram-negative, Gram-positive, and anaerobic coverage due to PTAs polymicrobial nature, followed
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by culture results and tailored treatment [1,2]. Antibiotics such as amoxicillin-clavulanate and ceftriaxone are
commonly used and can be complemented by vancomycin or linezolid for methicillin-resistant
Staphylococcus aureus (MRSA) coverage [2,8]. Despite clear guidelines, empiric antibiotic treatment is not
consistently followed [9]. Steroids are often prescribed alongside antibiotics to decrease dysphagia, trismus,
and time spent in the hospital [10]. Medical therapy has been shown to be equally eﬀective to drainage and
resulted in fewer sick days in some patients, lower opioid usage, and decreased soreness [1]. However, I&D
exhibits a success rate of 93-95%, and is a relatively inexpensive and simple procedure, making it the most
common treatment approach [11,12]. Therefore, the primary objective of this study was to evaluate how a
local hospital network’s EDs compared to generally accepted guidelines regarding the diagnosis and
management of potential PTAs with respect to attempted drainage, appropriate antimicrobial therapy, and
outpatient management. Secondary objectives focused on quality of patient care regarding imaging studies
performed, medications prescribed, and appropriate level of care.
This article was previously presented at the American College of Emergency Physicians Conference 2020.

Materials And Methods
Data collection
After Institutional Review Board approval, a retrospective chart review was done utilizing the International
Classiﬁcation of Diseases (ICD)-10 codes. The following ICD-10 codes were used: J36 (peritonsillar
abscess), K12.2 (cellulitis and abscess of mouth), J39.1 (other abscess of pharynx), J39.0 (retropharyngeal
and pharyngeal abscess), J39.2 (other disease of the pharynx), J02 (acute pharyngitis), and R07.0 (pain in
throat). Multiple ICD-10 codes were used to ensure inclusion of all eligible patients. All patients seen within
one calendar year from March 2019 to March 2020 were included in the study. Inclusion criteria were a
diagnosis of a PTA or peritonsillar cellulitis and presentation at an in-network ED. Exclusion criteria were no
PTA or peritonsillar cellulitis diagnosis or presentation at any location other than an in-network ED. After the
initial search was completed, all charts were reviewed by an individual chart reviewer to determine eligibility
based on the eligibility criteria. Patients with peritonsillar cellulitis were included in an eﬀort to include all
cases of PTAs. Imaging studies related to these patients were reviewed to eﬀectively rule in or out PTA.
Portions of the electronic medical record reviewed included history, physical examination, diagnostic
studies, hospital course, medications given, and readmission within 10 days. Patients were compared to the
aforementioned guidelines for PTA treatment. Descriptive analysis was performed using Jeﬀrey's Amazing
Statistics Program (JASP) version 0.9.0.1 (The Netherlands: University of Amsterdam).

Results
Six hundred twenty-one patients were identiﬁed utilizing ICD-10 codes. Of these, 295 patients did not have
a PTA or peritonsillar cellulitis diagnosis and 186 patients did not present to an in-network ED and were
excluded from the study, leaving 140 patients in the study (Figure 1). Sixty-seven (56%) patients were male
and 53 (44%) were female. The average age was 31.3 years (15.74 SD) ranging from two years of age to
90 years of age. The average length of stay was 1.4 days (1.56 SD) ranging from zero days to 11 days
(Table 1).
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FIGURE 1: Patient records selected for analysis.

Patient and Location Presentation Characteristics
Age (Mean) - year (SD)

31.7 (16.21)

Gender, N (%)
Male

67 (56%)

Female

53 (44%)

Presenting Hospital, N (%)
Main Hospital

85 (71%)

Secondary Hospital

21 (18%)

Smaller Hospital

14 (11%)

Admission Location, N (%)
Emergency Department

35 (29%)

Observation Unit

21 (18%)

Inpatient

64 (53%)

Length of Stay (Mean) - D (SD)

1.5 (1.61)

TABLE 1: Patient and location presentation characteristics of patients with a
peritonsillar abscess.

One hundred (71%) patients presented at our primary hospital (a level one trauma center with a separate
children’s ED), 61 (61%) were admitted to the inpatient service, and 19 (19%) were held for observation.
There were 24 (17%) patients who presented at the level two trauma center hospital, ﬁve (21%) were
admitted to the inpatient service, and two (8%) were held for observation. There were 16 (12%) patients
seen at smaller hospitals within the hospital network ﬁve (31%) were admitted to the inpatient service, and
two (13%) were held for observation. Out of all patients, 71 (51%) were admitted to the hospital, 23 (16%)
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were held for observation, and 46 (33%) were discharged from the ED. Patients’ presenting symptoms were
documented. The majority, 121 (86%), had either dysphagia, odynophagia, or hoarseness documented in
their initial evaluation. Of the patients without recorded dysphagia, odynophagia, or hoarseness, 7/19 (37%)
were placed on a nothing by mouth (NPO) diet.
After reviewing the patients’ initial presentation, pertinent portions of their hospital stay were recorded
including imaging, consults, PTA drainage, and medications given. All patients’, with a PTA ICD code,
imaging results were reviewed, and those that did not have a visible PTA on imaging, 20/140 (14%), were
considered to have peritonsillar cellulitis and were not included in analysis. Most patients received some
form of imaging, with 94 (78%) patients receiving a CT scan, four (3%) received a point of care ultrasound
and CT scan, two (2%) received an x-radiograph, and only 20 (17%) received no imaging. Patients who
received a CT scan were more likely to be admitted, with a chi-square p-value of 0.003. Of the same
patients, only 58 (52%) had an identiﬁed abscess on imaging, 40 (34%) had a potential abscess on
imaging, and 18 (16%) had no abscess on imaging (Table 2). In the case that the radiologist could not
concretely rule in or out a PTA on imaging, “a potential abscess” was listed within the report.

Imaging Performed, N (%)
CT Scan

94 (78%)

PoCUS and CT Scan

4 (3%)

X-Ray

2 (2%)

No Imaging

20 (17%)

PTA Drainage Performed, N (%)
ED Provider

19 (16%)

ENT Provider

25 (21%)

OR Drainage

12 (10%)

ED and ENT Provider

1 (1%)

ED Provider and OR

1 (1%)

No Procedure

62 (51%)

TABLE 2: Imaging and procedures performed during hospital stay.
CT- computerized tomography; PoCUS- point of care ultrasound; ED- emergency department; ENT- ears, nose, and throat; ORoperation room

Transferred patients
Nearly a quarter of patients, 22/120 (18%), were transferred from smaller in-network hospitals to the central
hospital for PTA management, despite resources available for aspiration, imaging, and overnight
observation at the presenting hospital. Of these patients, 10 (45%) were admitted to the intensive care unit
(ICU) and 11 (50%) were placed on airway watch. Only one (4%) transferred patient had documented
oxygen desaturation and none required nasal or oral airway support. Only 10 (45%) patients received PTA
drainage and 12 (55%) of transferred patients received no PTA drainage.

Consults
The majority of patients received one or more consult, 74/120 (62%) PTA patients received only an
otolaryngology consult; eight (7%) received otolaryngology and medicine consult for ICU admission; 15
(12%) received otolaryngology and other specialty consult such as anesthesia, infectious disease, or
general surgery; and 23 (19%) received no consults.

Procedures done
Only 19 (16%) patients had PTA drainage performed by an ED provider, 25 (21%) had PTA drainage
performed by an otolaryngology provider at bedside, one (1%) had attempted PTA drainage performed by
an ED and otolaryngology provider, 12 (10%) had PTA drainage by an otolaryngologist in the operating
suite, and one (1%) patient had attempted PTA drainage performed by an ED provider and in the operating
suite by an otolaryngologist. Most patients, 62 (51%), had not PTA drainage (Table 2).
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Throughout their stay, only two (2%) patients experienced an oxygenation desaturation (deﬁned as less
than 90% on pulse oximeter). The remaining 118 (98%) patients had no recorded desaturations. Only one
(1%) patient received a nasal or oral airway and two (2%) received supplemental oxygen. Additionally, 21
(17%) patients were held in an observation unit.

Medications prescribed
Initial medications and medications prescribed with discharge were extracted from the patients’ charts. The
majority of patients, 78/120 (65%), were given a penicillin derivative, seven (6%) were given penicillin and
second class of antibiotic, 33 (28%) were given clindamycin, and two (1%) were given no antibiotics
throughout their hospital stay. Along with antibiotics, 95 (79%) patients received steroids throughout their
stay. Upon discharge, 95 (79%) patients were prescribed a penicillin derivative antibiotic, 22 (18%) were
prescribed clindamycin, and three (3%) were not prescribed antibiotics. Only two (29%) patients had
received PTA drainage in their original stay and seven (6%) were seen at the hospital within 10 days of
discharge.

Discussion
Over half (53%) of patients presenting for a PTA were admitted to a hospital and 83% of patients received
imaging. This management is contrary to current guidelines and recommendations [2]. Current literature
reports that 80% of patients with a PTA are discharged from the ED, whereas the institution discharged only
47% of patients presenting to the ED with a PTA [4]. Additionally, only two patients had a documented
oxygen desaturation throughout the stay and one patient received a nasal or oral airway. However, 18
patients were admitted to the ICU for fear of airway compromise, although none exhibited progression of
disease. Our ﬁndings suggest that this level of care is not necessary and contributes to higher healthcare
costs with no added quality.
Patients transferred from smaller hospitals in the network to the largest hospital did not beneﬁt from the
higher level of care. Of 22 patients, 10 (45%) were admitted to the ICU and 11 were placed on “airway
watch”, despite an ENT provider being present at each hospital. Even with the higher level of concern for
airway compromise, only one of these patients had an oxygen desaturation and none were given nasal or
oral airway support.
However, medical management of PTAs in this hospital network was consistent with existing literature.
Steroids are often given to decrease pain, dysphagia, and time in the hospital and are commonly
administered with antibiotics [13]. Nearly 80% of patients were given a penicillin derivative; 79% of patients
were given steroids during their stay; and nearly 79% of patients were given a penicillin derivative upon
discharge, consistent with treatment guidelines for bacteria that commonly cause a PTA [1]. Unfortunately,
the readmission rate was 6%, higher than reported in the literature. One reason for this may be absent or
delayed drainage of PTA.
I&D is a common treatment for PTAs and was underutilized within this hospital network. Less than half of
the patients (38%) underwent I&D at bedside and of the patients that did, only 46% of them had an I&D
performed by an ED provider. Three patients had ultrasound-guided drainage by an ED provider. The
remaining 54% had an I&D performed by an ENT provider. The theoretical risk of damaging the carotid
artery may act as a deterrent for some providers, but has not been reported in the literature [5]. Additionally,
over half of patients who received a CT scan had an identiﬁed PTA and would have beneﬁted from PTA
drainage in the ED. Only four patients had a point of care ultrasound, and all of these patients also had a
CT scan. This highlights the underutilization of ultrasound for diagnosis and treatment. Training utilizing
ultrasound for PTA drainage has been found to increase a resident's comfort level with PTA management
[11]. The ED at the institution is the primary location for a large Emergency Medicine residency program.

Limitations
The limitations of this study relate to retrospective chart review and based upon provider recall.
Documentation may not have included all pertinent symptoms or provider reasoning for management
decisions. Additionally, this was done as an internal study, and may not be representative of PTA
management nationwide. However, this study does contain a large sample size and gives insight to how
smaller hospitals with limited resources may manage PTAs.

Conclusions
Within this study period, management of PTAs was inconsistent with current guidelines based on the
literature from several diﬀerent disciplines. By decreasing the amount of imaging performed for patients with
a PTA, performing an I&D within the ED, decreasing the number of patients transferred from smaller
hospitals, and decreasing the number of patients admitted to the ICU, signiﬁcant cost savings can be
achieved, and emergency medicine residents would receive greater insight to PTA diagnosis and
management. Antibiotic management was consistent with guidelines. Future quality improvement projects
could aid in facilitating these changes.
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Additional Information
Disclosures
Human subjects: Consent was obtained or waived by all participants in this study. Lehigh Valley IRB
issued approval STUDY00000387. Title of Study: HSRD: Peritonsillar Abscess Capstone Project The IRB
determined that, as submitted, the information sought in this proposal is not generalizable and therefore the
project referenced above does not meet the regulatory requirements for human subject research as deﬁned
by 45 CFR 46.102(d). As such, submission to and oversight by the IRB is not required. Please note that
there are no informed consent considerations required for nonresearch quality projects, but HIPPA
protections still apply. This determination applies only to the activities described in the IRB submission and
does not apply should any changes be made. If changes are being considered and there are questions
about whether IRB review is needed, please submit a study modiﬁcation to the IRB for a determination. You
can create a modiﬁcation by clicking Create Modiﬁcation/CR within the study. Animal subjects: All authors
have conﬁrmed that this study did not involve animal subjects or tissue. Conﬂicts of interest: In
compliance with the ICMJE uniform disclosure form, all authors declare the following: Payment/services
info: All authors have declared that no ﬁnancial support was received from any organization for the
submitted work. Financial relationships: All authors have declared that they have no ﬁnancial relationships
at present or within the previous three years with any organizations that might have an interest in the
submitted work. Other relationships: All authors have declared that there are no other relationships or
activities that could appear to have inﬂuenced the submitted work.
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